Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 1593 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus

Ved Paresh, Shah Samrat

Year : 2012| Volume: 16| Issue : 7 | Page no: 110-113

   This article has been cited by
1 Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: the OMEGA study
Ibrahim El Ebrashy,Nabil El Kafrawy,Rana Raouf,Diana Yousry
Diabetes Research and Clinical Practice. 2020; : 108042
[Pubmed]  [Google Scholar] [DOI]
2 Le diabète de type 2 au stade de l’insuline : Quelle place pour les inhibiteurs de la DPP-4 ?
S. Halimi,B. Charbonnel,P. Monguillon,S. Dejager
Médecine des Maladies Métaboliques. 2015; 9(1): 53
[Pubmed]  [Google Scholar] [DOI]
3 Sulfonylurea Glimepiride: A Proven Cost Effective, Safe and Reliable War Horse in Combating Hyperglycemia in Type 2 Diabetes
Udaya M. Kabadi
Journal of Diabetes Mellitus. 2015; 05(04): 211
[Pubmed]  [Google Scholar] [DOI]
4 Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
Gagik Radikovich Galstyan,Svetlana Viktorovna Sergeeva
Diabetes mellitus. 2015; 18(4): 87
[Pubmed]  [Google Scholar] [DOI]
5 Combination Therapy With DPP-4 Inhibitors and Insulin in Patients With Type 2 Diabetes Mellitus: What Is the Evidence?
Bernard Charbonnel,Anja Schweizer,Sylvie Dejager
Hospital Practice. 2013; 41(2): 93
[Pubmed]  [Google Scholar] [DOI]


Read this article